A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects

NCT05857215 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Disease

Interventions

DRUG: amilo-5MER

Sponsor

Galmed Pharmaceuticals Ltd

Collaborators

[object Object]